EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Imaging versus reality: How sensitive is positron emission tomography/computed tomography in early breast cancer lymph node assessment?

Haryax Pathak, G. C. Raghunandan, Piyush Chandra, Jitesh Desai

Annals of Oncology Research and Therapy · 2026

DOI: 10.4103/aort.aort_15_25 ↗
AbstractBibliografische Angaben

Abstract

Abstract: INTRODUCTION: Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a nuclear imaging modality employed for evaluation of distant metastasis, response to chemotherapy or recurrence of disease in early breast cancer (EBC), but its role in diagnosing locoregional axillary nodal disease is still unclear. Current guidelines dictate sentinel lymph node biopsy (SLNB) for evaluation of axillary involvement followed by axillary lymph node dissection (ALND). We conducted a study to test the sensitivity of FDG PET/CT in detecting lymph node metastasis in EBC, compared with post-ALND histopathological examination. MATERIALS AND METHODS: In a prospective single-center study at a rural tertiary hospital, 33 women with newly diagnosed EBC underwent FDG PET/CT for primary disease status and abnormally increased axillary nodal FDG uptake. These results were then compared with postoperative ALND histopathology report and the data collected were subjected to appropriate statistical analysis. RESULTS: Out of 33 patients who underwent FDG PET/CT followed by modified radical mastectomy and ALND, 24 patients had T2 lesions and 9 had T1 lesions. The sensitivity, specificity, and positive and negative predictive values for nodal metastasis on PET/CT were 50%, 100%, 100%, and 62.5%, respectively. CONCLUSIONS: FDG PET/CT exhibits moderate sensitivity and high specificity for axillary nodal metastasis in EBC. It is not advisable to use FDG PET/CT as a standalone investigation for axillary nodal staging in EBC as it cannot replace SLNB. SLNB remains the investigation of choice for nodal staging and requires capacity building, infrastructure, and training, especially in resource-poor institutions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →